CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.

Zheyi YanJianli ZhaoLu GanYanqing ZhangRui GuoXiaoming CaoWayne Bond LauXin MaYajing Wang

Published in: PloS one (2017)

CTRP3 may serve as a novel biomarker for DR severity. CTRP3 may represent a future novel therapeutic against DR, a common ocular complication of diabetes.

Keyphrases

diabetic retinopathy
optical coherence tomography
editorial comment
poor prognosis
type diabetes
high glucose
cardiovascular disease
skeletal muscle
diabetic rats
glycemic control
current status
endothelial cells
binding protein
long non coding rna
optic nerve
stress induced